DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Tuesday.
Several other equities analysts have also recently issued reports on XRAY. Morgan Stanley dropped their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Jefferies Financial Group downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their price target for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. Needham & Company LLC reissued a “buy” rating and issued a $25.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, February 11th. Finally, Mizuho began coverage on shares of DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 target price for the company. Ten research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA has an average rating of “Hold” and an average price target of $25.85.
Read Our Latest Stock Report on DENTSPLY SIRONA
DENTSPLY SIRONA Trading Up 0.7 %
Institutional Investors Weigh In On DENTSPLY SIRONA
Institutional investors have recently modified their holdings of the company. CWM LLC raised its holdings in DENTSPLY SIRONA by 118.2% during the third quarter. CWM LLC now owns 7,337 shares of the medical instruments supplier’s stock worth $199,000 after purchasing an additional 3,975 shares during the last quarter. Blue Trust Inc. raised its stake in shares of DENTSPLY SIRONA by 15.1% during the 3rd quarter. Blue Trust Inc. now owns 6,492 shares of the medical instruments supplier’s stock worth $162,000 after buying an additional 854 shares during the last quarter. Sequoia Financial Advisors LLC purchased a new stake in shares of DENTSPLY SIRONA in the 3rd quarter worth about $230,000. Country Club Bank acquired a new stake in DENTSPLY SIRONA in the 3rd quarter valued at about $4,084,000. Finally, Allworth Financial LP increased its holdings in DENTSPLY SIRONA by 40.2% during the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock valued at $59,000 after acquiring an additional 625 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
See Also
- Five stocks we like better than DENTSPLY SIRONA
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Consumer Discretionary Stocks Explained
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.